FR1450840A - Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes - Google Patents

Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes

Info

Publication number
FR1450840A
FR1450840A FR25070A FR25070A FR1450840A FR 1450840 A FR1450840 A FR 1450840A FR 25070 A FR25070 A FR 25070A FR 25070 A FR25070 A FR 25070A FR 1450840 A FR1450840 A FR 1450840A
Authority
FR
France
Prior art keywords
9beta
10alpha
steroids
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR25070A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to FR25070A priority Critical patent/FR1450840A/fr
Priority claimed from GB3054865A external-priority patent/GB1095665A/en
Application granted granted Critical
Publication of FR1450840A publication Critical patent/FR1450840A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/10Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
FR25070A 1965-07-19 1965-07-19 Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes Expired FR1450840A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR25070A FR1450840A (fr) 1965-07-19 1965-07-19 Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3054865A GB1095665A (en) 1965-07-19 1965-07-19 Novel 9ª‰, 10ª‡-steroids and a process for the manufacture thereof
FR25070A FR1450840A (fr) 1965-07-19 1965-07-19 Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes

Publications (1)

Publication Number Publication Date
FR1450840A true FR1450840A (fr) 1966-06-24

Family

ID=26164847

Family Applications (1)

Application Number Title Priority Date Filing Date
FR25070A Expired FR1450840A (fr) 1965-07-19 1965-07-19 Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes

Country Status (1)

Country Link
FR (1) FR1450840A (fr)

Similar Documents

Publication Publication Date Title
CH461500A (fr) Procédé de préparation de nouveaux isoindolinosulfonylurées
CH468425A (fr) Procédé de préparation de nouveaux polyamides
FR1482577A (fr) Procédé de préparation de béta-alkyl-alpha, oméga-diaminoalcanes
FR1512869A (fr) Procédé pour la préparation de nouveaux éthers propynyliques
FR1505657A (fr) Procédé pour la préparation de diphénylalcoylamines substituées
CH481115A (fr) Procédé pour la préparation de nouvelles cinnamylpipérazines
FR1446515A (fr) Procédé pour la préparation de nouveaux 9beta, 10alpha-stéroïdes
CH480318A (fr) Procédé de préparation de 7a-méthyl gona-4,9-diènes
CH474516A (fr) Procédé de préparation de nouveaux 2,6-dihalogéno-isonicotinamides
FR1503599A (fr) Procédé de préparation de nouveaux 3-amino-cholestanes
FR1499544A (fr) Procédé pour la préparation de 11beta-hydroxy-9, 10alpha-séroïdes
CH485626A (fr) Procédé pour la préparation de nouveaux phénols
FR1491587A (fr) Procédé de préparation de nouveaux 19-nor-androstatriènes
FR1513463A (fr) Procédé de préparation de nouveaux tri-iodo-diaminobenzènes
FR1510878A (fr) Procédé pour la préparation de benzindènes
FR1443577A (fr) Procédé pour la préparation de nouveaux 9beta, 10alpha-stéroïdes
FR1452696A (fr) Procédé pour la préparation de nouveaux 9beta, 10alpha-stéroïdes
FR1450840A (fr) Procédé pour la préparation de nouveaux 9beta,10alpha-stéroïdes
FR1459000A (fr) Procédé perfectionné pour la préparation du trioxanne
FR1463725A (fr) Procédé de préparation de nouveaux imidazoles
OA02517A (fr) Procédé pour la préparation des tritylamines.
FR1404481A (fr) Procédé pour la préparation de nouveaux 3-éthers de la nu-(alpha, gamma-dihydroxy-beta, beta-diméthyl-butyryl)-propylamine
FR1502714A (fr) Procédé pour la préparation de 1, 2-époxy-9beta, 10alpha-stéroïdes
FR1491588A (fr) Procédé de préparation de nouveaux 7-méthyl-19-nor-androstadiènes
FR1494371A (fr) Procédé pour la préparation de 5beta-eta-6-céto-stéroïdes